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I. Introduction of Hypothesis and Possible Values of the Finding

It has been estimated that approximately

9%

of people

with cancer metastatic to bone develop a hypercalcemia
sometime during the course of their disease.

(1)

This is

seemingly rather easily explained on the basis of extensive
osteolysis with mobilization of sufficient quantities of
calcium to exceed the kidneys' excretory capacity.
Some malignancies, however, haire been associated with a
hypercalcemia without any evidence of bony metastasis.

Further-

more the hypercalcemia increases with tumor size and decreases
with surgical and chemotherapeutic extirpation of the tumor
or soft tissue metastasis, and again increases with recurrence.

,-

Associated with the hypercalcemia there is often a hypercalcuria hypophasphatemia, and decreased tubular
phospha°t;e.

reabso~ption

of

These findings have been .found most frequently in

tumors of the lung, kidney, and breast as tolell as lymphomas
and leukemia.

Other tumors that have been associated with

hypercalcemia include the stomach, cervix, bladder, uterus,
tonSils, cartilage, and neuroblastomas.

(1)

The above blood chemistry findings suggestive of hyperparathyroidism led Albright and Reifersteln, in 1948, (2)
to propose that some tmnors produced parathormone, or a parathormone like substance.

Since that time there have been

numerous reports of similar cases of hypercalcemia, hyper calcuria and hypophosphatemia without bony metastasis and normal

(1)

normal parathyroid glands. (3,4,5,6,7 & 8 & 14)

In these

patients other causes of hypercalcemia such as Vitamin D
intoxication, prolonged

irr~obilization,

milk alkali syndrome,

Boecks Sarcoid, and primary bone disease were adequately
ruled out.

Stone and Waterhouse, in 1961, (9) presented a

similar case in which they found hyperplastic parathyroid
glands and postulated that the trunor produced a trophic
f!

substance Xu.

This patient 1'\TaS also cured of her hypercal-

cemia by a subtotal parathyroidectomy.

However this appears

to be an isolated case and no similar ones can be found in
the literature.
If some neoplasms do actually produce parathormone, the
clinical importance of this finding is vast.

Serum calcium

levels may become an important screening test for malignancies as well as other more discrete methods of evaluating
parathyroid activity.

Also, since the apparent hrunoral

activity parallels the truaor activity, these tests can be a
good measure of the therapeutic effectiveness of antitttmor
drugs and surgery, and a measure of rec·urrence alerting the
phYSician to the need of further and/or more drastic measures.
Furthermore the hypercalcemia in itself is often a terminal
factor in cancer deaths and an understanding of the nature of
one of the causes of

h~rpercalcemia

treatment of this problem. (10)

(2)

can lead to more effective

II. Typical Case and Other Reports from the Literature
It is germane to the thesis at this time to present a
rather

t~~ical

case which illustrates findings consistent

with a parathorraone secreting tumor:

,-

(~_)

A forty-eight year old woman was ad.mitted
on June 27, 1950, because of L~O pound weight loss,
anorexia and vomiting of four months' duration.
On examination the striking findings were -the
cachexia and a soft, non..,tender multilobular mass
arising in the left adnexal region and extending
halfway up to the urn.bilicus. She was anemic. The
erythrocyte sedimentation rate was 117 mm. in one
hour. The urine concentrated to 1.023 and was
negative for albwnin, sugar and Bence-Jones protein. The urea nitrogen was 16 mg. per cent.
The serum calcium re.nged between 15.7 and 17.9
mg. per cent, with serum phosphorus of 2.1 to
3.1 mg. per cent. The serum albumin was 3.6 gm.
per cent and globulin 2.8 gm. per cent. X-ray
of' the chest was normal. Gastrintestinal X-ray
study, barium enema and protoscopy were normal.
Skeletal survey showed min1mel deminerali.zation
with no changes suggestive of hyperparathyroidism
or metastatic malignancy. The lamina dura of the
teeth wa.s intact. The electrocardiograrn was
normal except for a Q-T interval of 0.28 at a
rate of' 110.
It was thought that the patient had hyperpaI'athyroidism and an ovarian neoplasm. Because
of the irr~ediate dangers of' hypercalcemia it was
decided to do an exploration of' the neck first.
This was done under pentothal, nitrous OXide,
ether and cyclopropane. Shortly af'ter induction
and before insertion of the intratracheal tube,
her he2.rt stopped. The chest was opened and the
hee.rt was found in diastole. It was massaged B.nd
spontaneous contractions began. It was thought
safe to continue the operation and exploration of'
the neck proceeded uneventfully. Two parathyroid
glands on the left and one on the right were
identified and appeared grossly normal. A small
0.5 em. node was removed in the hope that this
nd.ght be an adenoma but on section this proved
to be a normal lymph node. Because of the previous cardiac arrest the sternum was not split.
She made an uneventf'ul recovery from these

(3 )

procedures, but there was no change in her
serum calcium which continued to range between
14.1 and 17.9 mg. per cent. It was felt that a
reasonable effort had been made to exclude a
parathyroid adenoma and that one should proceed
against the ovarian neoplasm.
At laparotomy a large multicystic tmnor was
found arising from the pelvis and extending up
to the l...uubilicus. No gross metastases i,,1ere noted.
A bilateral salpingo-oophorectomy and total
hysterectomy were done. All of the right ovary
could not be removed from the pelvis. The histopathologic diagnosis Trias papillary adenocarcinoma
of the ovary. Careful search did not reveal
parathyroid tissue, teratoma or unusual calcification. Tv~or tissue was also found in the left
ovary. The uterus showed no evidence of an
estrogen effect. Postoperatively the patient
did well. Three days postoperatively her serum
calcium was 11.2 mg. per cent. Six days postoperatively it was 10.3 mg. per cent and the
serum phosphorus was 3.1 mg. per cent. The serD~ alkaline phosphatase showed a transient rise
to 7.1 Bodansky units (B.U.). Twelve days
later radiotherapy was initiated to a total
turnor dose of LI.300r. The patient gained sixteen
pounds and her serum calcium remained at 10.5
mg. per cent with phosphorus of 3.4 mg. per cent.
Five months after the operation she lost a few
pounds in weight (serum calciu..rn 11.6, phosphorus
2.3 mg. per cent, sedimentation rate 110). Six
months after the operatlon a mass became palpable
in the lower right quadrant, and the serum calcium rose to 13.4, then 15.5 mg. per cent, the
phosphorus to 3.~- mg. per cent, then 4.0 mg. per
cent with spinal fluid calciuM 5.4 and phosphorus
1.4 mg. per cent. After temporary improvement
she began to fail and dependent edema and severe
abdominal pain developed. The serum calciura
then was 16.1 mg. per cent. At the patientls
request, she was transferred to a hospital nearer
her home. Skeletal X-ray studies there in July,
1951, failed to reveal bony metastases. She
died suddenly one week later. Permission for
autopsy could not be obtained.
Plimpton 8.nd Gellhorn (4.) have a series of ten patients
with malignant disease and normal bones.

(4)

They all exhibited

symptomotology characteristic of hypercalcemia and blood
chemistry consistent wdi.th hyperparathyroidism.
causes of hyperc8.lcemia were ruled out _

Other

Removal of the

primary turnor in 3 of the patients was associated

'ltli th

prompt return to normal of the serum calciurll and phosphorus
and the alkaline phosphatase when elevated.

The parathyroid

glands were invariably found to be normal at the time of
operation or autopsy_

This series susgested to them that

some humoral substance was produced by these tumors although
they could not rule out the production of some substance
which binds calcium and transports it in excessive amounts
causing a secondary

h~rperpay·athyroidism.

Nyers, in 1960, (11, 12,

&,

13) presented a series of

430 patients having hypercalcemia associated with malignant
turnors.

Of these, roentgenograms of the skeleton for meta-

stasis were negative in

50.

Therefore,

14%

56

patients and not done in another

had hypercalcemia without bony metastasis.

Included in his series were kidney, 17%; lung, 19%; cervix,

50%;

and lymphoma,

38%; without bony metastasis. One particu-

larly interesting presentation in his paper was a problem in
differential diagnosis between primary hyperparathyroidism
and hypercalcemia without bony metastasis:

(5)

f

-

33 year old female

59 year old male

carcinoma of the cervix,
2 years

carcinoma of the lung, 2 years

Historx

+

Previous cancer treated

+

+

Thirst weight loss and
polyuria

+

--------------------------------------------------+

Evidence suggesting
recurrent cancer

,!;:aboratory

.&il~......,

~

+

15.2

Serum Ca++

15.5

2.2

Serum Phosphorus

2.7

14.1 B.U.

Alkaline Phosphatase

11.7 B.U.

430

Urinary Ca++ mg

176

12

BUN

18

3.7

Serum K+

5.7

29

Serum HCO 3-

22

Normal

Bone I"larrow

Hypocellular

(6)

24h

--------------------------------------------------------------------Demineralization

X-ray

Demineralization

Metastatic lung CA Bone not invaded
parathyroid, normal.

Diagnosis

No recurrence parathyroid adenoma.

Special tests - phosphate clearance, calcium tolerance and
response to cortisone were not appreciably different.

This then shows how closely primary hyperparathyroidism
can be mimicked and lends credence to the secretory theory.
Myers (13) also noted that the rate of growth or
functional capacity of a tumor may be reflected in serml1
and urinary calciurn.

He suggests that calcium studies

may provide a precise "lay in which to measure changes in
a tumor in response to treatm.ent and this data may be useful
in screening antitumor agents.
Connor, Thomas, and Howard, in 1956, (3) presented two
cases of hypercalcemia and malignancy without skeletal
m.etastasis.

One was a 69 year old male who preoperatively

had increased Ca++ and decreased

1'04=. A tumor of the lung

was resected and the Oa++ returned to normal by the
postoperative day.

L~th

Four months later the Oa++ increased

and local tumor growth vvas noted.

Shortly before death the

Oa++ decreased and at autopsy the tUlllOr was found to be

completely necrotic.

The parathyroid glands and bones were

normal.
Schatten, Ship, et aI, in 1959, (14) reported a case
of a patient with hypercalcemia and hypophosphatemia associated
with squamous cell carcinoma of the vulva.

There was a

direct correlation between the presence of tUiuor and the
serum abnormalities.
A fall of serum calcium and a rise of serum phosphorus
followed excision of the tlrraor and a second rise in serum
calcium t'ITith a fall of serml1 phosphorus followed its growth.
The parathyroid glands were normal at autopsy and there were
no osseous metastasis.
Stone, Waterhouse, and Terry, in 1961, (9) presented the
case of a

34

year old woman with carcinoma of the cervix and

hypercalcemia without bony metastasis.

A subtotal parathy-

roidectomy was done which revealed a pathologic picture
consistent with secondary hyperplasia.
a persistent fall until death.

They felt that this represented

production of a trophic substance by the
ulated the parathyroids.

The serum Oa++ began

t~~or

which stim-

However a fourth pa.rathyroid gland

was found at autopsy and it is generally hopefully asslITlled
by surgeons performing a total thyroidectomy that a single
gland is adequate for normal parathyroid function.

This

1,'Uould not appear to be due to high preoperative Ca++ causing
temporary parathyroid suppression.

{~

(Q)
,v

Abouav, Berkowitz, and Kolb, in 1959, (15) reported a case
of masculin.izing hyperneprlI'oid ovarian tumor associated with
hypercalcemia and hypophosphatemia.
phosphate was

85%

Tubular reabsorption of

and there was a hypophosphaturia.

They

believe that this is the usual finding in cases of this t;ype
and therefore argue that the humoral substance is not parathOr!110ne because it lacks phosphaturic qualities.

They

believe that the hypophosphatemia in their case is due to
the normal body homeostatic mechanisms

~vhich

tend to main-

tain the physiochemical relationship ACa++ • AP04 _

= K.

In this belief then, they feel that the phosphate reabsorption
can be used to differenciate between primary hyperparathyroidism and parathorruomimetic turaors.

The sermu Ca++ fell and

the phosphate rose following removal of the tunlOr.
In the CPC of the New

}!~ngland

Journal of lViedicine, October,

1963, (16) a case of adenocarcinoma of the transverse colon
with extensive metastasis to the liver was presented.

This

patient had hypercalcemia, hypercalcuria and hypophosphatemia
without evidence of metastatic bone disease.
glands l>lere normal at autopsy.
alkaline phosphatase.

The parathyroid

The patient also had a high

Dr. Armen Tashjian, by use of a quanti-

tative complement fixation reaction and an antigen reacting
with the specific antiparathyroid hormone, antigen to Hparathyroid hormone n was detected, approximately 6 microgm. of
antigen per gram of primary tumor and 1 microgram of antigen

(9)

.~.

per gram of metastatic tumor.
rounding tissues.

No antigen was found in sur-

He uses an antiserurr! to bovine parathor-

mone which shows serologic cross reactivity with human parathormone (unpurified).

That this is actually parathormone

and not tissue components with antigenic cross reactivity
has not been definitely established.
Soldberg and Tashjian, et al (8) have a series of 18
patients, with chemical abnormalities associated ",lith tWllors
arising outside the parathyroid glands without bony metastaSeven are renal cell, 3 are bronchial, 2 ovarian carcinoma

sis.

and 1 each of endometriurn, bladder, vulva, generalized lymphoma plus reticulum cell sarcoma and hemangiosarcoma of the
".~

liver.

In 10 of the 18 cases parathyroid examination was

reported.

One was adenomatous, one hyperplastic, and eight

were normal.

In all 10 cases in which the tumor was removed

the serum calcium returned to normal but subsequently rose in

3 cases when the tUlIlor recurred.

The serum phosphate was

conSistently low in 11 of the 17 cases and the serma alkaline
phosphatase was elevated in 7 of 15 cases.
Finally, for variety, lrJoolner, Keating, and Blank (17)
presented a case of a woman who had primary hyperparathyroidism resulting from a parathyroid adenoma.

One year pre-

viously an adenocarcinoma of the breast had been surgically
removed.

Operation disclosed a parathyroid turnor that lllias the

site of metastasis from the adenocarcinoma of the breast.

(10)

III. iYIechanism of Action of Parathormone
If parathormone is indeed produced by some neoplasms, an
understanding of its action and effects is necessary to derive
any clinical benefits from this finding.
The parathyroid hormone has recently been isolated by
Rasmussen and Craig (18).

It is a polypetide with a mole-

cular weight of approximately 9,500 and is homogeneous by
counter current distribution, paper and column chromatography and ultra centrifugation and posses calcium mobilizing
and phosphaturic activity.

It can be partially hydrolysed

without complete loss of biologic activity and this is probably
the explanation for some false results obtained with cruder
extracts.
Parathormone has been found to have effects at four
target organs.

These include bone, the kidney, the gastro-

intestinal tract and the lactating breast.

The main biochemical

effect of this hormone seems to be associated with the transport of calcium across a variety of membranes (intestinal
epithelium, renal tubule, bone cells and mammary epithelium),
and it also seems to be involved in the uptake and turnover of
phosphate in the kidney and possibly other organs.
f.eripheral Effects of Parathormone on the

Kidne~

It seems well established that parathyroid hormone controls

(11)

the renal excretion of phosphate (19, 20, 21) but the manner
in which it does this is a subject of controversy, either by
increasing the glomerular filtration rate or by its control
over the tubular reabsorption or excretion.

However from the

work of Jacobs (22) and Hint and Thomas (23,

24)

it appears

that the more significant is the control of' tubular reabsorption or secretion of phosphate.

The bulk of the proof is

derived from experiments which show a rapid and sustained
increase in the urinary phosphate excretion with no change
in the clearance of inulin following adequate doses of
parathormone.

Unilateral perfusions of dog kidneys have

given similar results and retrograde infusions in the chicken
which has a I'enal portal system whereby only the tubule is
perfused have given simileI' results, i.e. increased phosphate
excretion without an increased GPR.
That this is primarily a secretory rather than a decreased
reabsorption response is supported by nicholson (25) 1111ho
suggests that the hormone controls the rate of phosphate
excretion at the distal tubule.

This is supported by the

work of deVerdier (26) who has shown an increased turnover
of' P32 in the renal tissues of animals tre8.ted with para.thyroid extract, which is more consistent with an increased
secretion rather than a reabsorption of phosphate.

Thus the

effect of !larathormone on the kidneys in regard to phosphate
is primarily an increased secretion of phosphate in the distal tubule.

This subject has not been thoroughly

however.

(12)

resolved~

Parathormone also seem.s to influence the rate of calcium
reabsorption by the renal tubule.

This is supported by data

from Albright and Ellsworth (2) that shows the initial effect
of ad..ministration of parathormone to a hypoparathyroid animal
is a fall in urinary calcium presumably due to an elevation
of the Tm for

calciu~

in the renal tubule.

It is only after

the plasma Ca++ becomes elevated that the hypercalcuria
develops.

Likewise following parathyroidectomy there is an

increased excretion of calcium and this is followed by
hypocalcuria only after the plasma Ca++ has fallen significantly.

This suggests that there is a decreased rate of

tubular reabsorption in the hypoparathyroid state.

-

Although

these actions upon the renal handling of Ca++ and P04= are
the most striking effects which follow the administration of
parathormone, other effects have been observed which may be
refined and also used as indicators of excessive parathormone
activity_
.Follov-ling rapid infusion of a purified parathyroid
extract in hypoparathyroid patients, Rich (27) found a rapid
onset of increased citrate excretion, an elevation in urinary
pH and an increase in total solute excretion.

Possible these

can be attributed to an increased tubular phosphate secretion
resulting in increased Na+ excretion and decreased

Ne:+~H+

change, an elevation of pH with resultant increased citrate

(13)

ex-

Na+ and H+ excretion.

The increased solute excretion is of

interest in view of the suggested diurectic effect of parathormonee
Perirheral Effects of Parathormone on Bone
1'he effects of parathormone on bone may be theorized as
follows:

(28)

The primary action of the hormone is to convert

potentially osteogenic cells from osteoblastic into osteolytic
cells, either multinucleated gia:4nt cells or an osteolytic
fibroblast which elaborates an

rgentophil fibrous tissue.
I

This results in increased bone ~esorption possibly by increasing acid production and increaSilng acid phosphatase activity,
resulting in the destruction of both matrix and bone mineral.
The release of the latter tends Ito elevate the level of both
AC a ++ and AHP04:';::.

This fall of lion product is buffered by
I

_

the withdrawal of calcimn and PlosPhate from the exchangeable
calcima of bone.

Since the kidley is more sensi ti ve and

responds more rapidly to the hOrrOne, the first effect upon
bone is probably withdrawal of clalcium and phosphate.

Bowever,

as soon as bone resorption is i1creased, and the ACa++ • ABP04 =
:.;:: K is returned to normal, calci'um and phosphate leave the extracellular fluid and return to the exchangeable bone mineral.
!rhus this compartment serves a bluffering function.

Although

this buffering function superficially appears to be a simple

physiochemical process, there is much to suggest that the
exchange is controlled by the cellular activity of the osteoblasts.

Although the initial effect of the hormone is to

decrease osteoblastic activity, the increased bone resorption
leads to a weakening of the bone, which leads to mechanical
stress and compensatory activation of resting osteogenic cells
into active osteoblasts, resulting in an increased rate of
bone growth and mineral accretion.

In mild hyperparathyroidism

this compensatol'Y change may be sufficient to maintain a
nearly normal amount of total bone tissue.

However, with

more severe deerees of hyperparathyroidism the compensatory
increase in osteoblastic

-

acti~ity

is insufficient, an

imbalance between osteogenesis and osteolysis develops, and
bone density as observed radiologically decreases, leading
to the classic picture of hyperparathyroidism with I'arefaction
of hone and fractures.

In this process the trabeculae and

certain areas of cortical bone appear to be more sensitive to
the action of the hormone and exhlbit the pathologic changes
sooner and to a greater degree than the major part of cortical
bone.
Perinheral Effects of ParathoHQone on the Gastrointestinal
-.. .·-----------·'--TraCt-----------'---

Parathormone seems to increase the rate of absorption of
Ca++ by the ~.I. tract (28).

This has been shown by taking

loops of bowel trom normal fmd parathyroidectomized rats.
The loops from the hypoparathyroid rats had a decreased
ability to develop and maintain a concentrated gradient of
cale-ium between serosal and mucosal fluid.

Thus parathyroid

hormone is necessary along with Vi ta...'11in D for adequate
calciv~

absorption.

For the purpose of this paper, the most important effect
of the hormone is that on the kidney, because the earliest
effects of hypersecretion v-JOuld be manifest in changes of
function in the organ most sensitive to its action, that is
the kidney.

The best explanation for this seems to lie in

the fact that in the dog kidneys, as estimated by Copp (29),
roughly 20-26% of the resting cardiac output perfuses the
kidneys in contradistinction to
bone.

3-7% total blood flow to the

Also Neuraan and Neu.man (30), by the use of isotopes

(deuteriwn), showed that injected deuteriwn equilibrates
alrllost immediately with soft tissues but is only
in bone at the end of

4

hours.

909; complete

Since parathyroid horrnone is

a relatively large molecule it would diffuse slowly through
the bone and depend on local blood flow to get to its site
of actioX}, the bone cells.

This system has an. inherent

stabili ty tending to smooth out slight cnan:;es in circulating
hor:rnone and would be slow to respond to larger variations in
hormone concentrate.

rEhe kidney, on the other hand, would have

all cells reached essentially Simultaneously and would be more
sensitive to small changes in the concentration of circulatory

(16)

hormone.

By using phosphate excretion as a test or renal

response and an increase in serum calciv.1i1 as an indicator
or osseous response, the difference between the onset of
action of parathormone can be shown.

If adequate doses or

par'athormone are given the maximal renal response is obtained
in

15-45

minutes; whereas, the increase in serum calcium

occurs in six or more hours (31).

Also if serum Ca++ is

decreased by the use of EDTA a change in the urinary excretion
of phosphorus occurs H'i thin 20 minutes.
The erfect on the kidney is thus more rapid, but also
limited in magnitude.

During prolonged administration or

the hormone the serum calcium will continue to increase until
death occurs.

However after a certain doseage level no

further effect upon urinary phosphate excretion can be
obtained (28) and despite an increased Tm for calcium, when
a significant hypercalcemia occurs, hyperca1curia ensues.

The

effect of parathyroid hormone can be summarized thusly:

Response

Bone

Kidney

G.I. Tract

Onset

Slow

Rapid

InteFlnediate

Sensitivity

Insensitive

Sensitive

Magnitude

Unlimited

Limited

(17)

Limited

From the above then it is possible to conceive the
regulation of' parathyroid activity by regulation of' ACa++.
The kidneys are a rapid and sensitive regulator which respond
to small hormone concentration and in a limited capacity;
whereas, the bone is slow to respond and insensitive, but
of' nearly unlimited capacity.

Thus, a f'all in the ACa++ of'

the plasma stimulates the parathyroid glands to secrete
more hormone.

The hormone acts upon at least three peri-

pheral tissues, the kidney, the bone, and the gastrointestina.l tract.

Its ef'f'ect upon the kidney is to increase the

tubular resorption of calciu.m; upon the bone to increase
resorption; and upon the gastrointestinal tract to increase
absorption.

All these effects tend to elevate directly the

ACa++ of plasma, which in turn shuts off the further production of hormone by the gland.

In addition, an increased rate

of bone resorption leads to an increased release of phosphate
into the plasma.

However, the hormone has an additional

action upon the kidney, that of increasing distal tubular
secretion of phosphate.
of A

HPO~_

= which

This effect results in a lowering

usually more than offsets the rise produced

by the resorption of bone.

The net result is a decrease of

A
= which leads to an increase of ACa++' due to their
EP04
interrelationship (ACa++.AHP04= =K).

(18)

IV. Symptoms of Hypercalcemia

Since hypercalcemia is often the cause of the presenting
complaints of these patients, and the symptoms are a rough
guide to the therapy, it is imperative that one be

f~uiliar

with the effects of hypercalcemia. (32)
The various manifestations of hypercalcemia rnay be
categorized by their effect on the nervous system, gastrointestinal tract, kidney, heart and metabolic alterations.
A high calcium level results in a diffuse disturbance in
the electrical activity of the brain which can be demonstrated
by an electroencephalogram.

The resultant s'Jrn1ptoms are

lassitude, somnolence and stupor which progress eventually
to coma and death.

There also may be occasional convulsions

and variable changes in the deep tendon reflexes.
The gastrointestinal symptoms are prominent and include
anorexia, nausea, vomiting and constipation although occasionally diarrhea.

There may also be duodenal ulcer disease and

pancreatitis.
The effect on the kidney is the inability to concentrate
urine with a resultant polyuria and polydipsia.

There also

seems to be a direct effect on the distal tubule with loss of
potassi~~,

sodiunl, and magnesium and subsequent hypokalemic

alkalosis.
The effects on the heart are usually changes in electrical
acti vi ty of the myocardiUt"11 t'l1"i th a shortened Q,T interval,

(19)

.-

lowering of the T waves and lowering or sagging of the P waves.
The effect on skeletal muscle seems to be depressant with
resultant muscle weakness.

(20)

V. Differential Diagnosis of Hypercalcemia

In order to qualify for the category of a "parathormone
secreting neoplasm" it is mandatory that all other possible
causes of hypercalcemia be ruled out.
The first thing that comes to mind in these days of
generalized useage of nonprescription vitamins is hypervitaminosis D.

Since D is a fat soluble vitamin it cannot

be excreted by the kidney and thus is cmTlulative.
here is usually the history.

The clue

Also in Vitamin D intoxication

there is usually a hyperphosphatemia which is not characteristic of the syndrome under consideration. (33)

A more

refined test is a trial of therapy with cortisone which is
said to be antagonistic to Vi tarnin D and would thus lower
serura calciuu...
About 10% of patients with sarcoidosis have hypercalcemia
and they may have hypercalcuria with or without hypercalcemia.
Many investigators (34, 35) (37) feel this is due to an endogenous hypervitaminosis D and cortisone treatment will indeed
reduce the hypercalcemia and can thus be used as a diagnostic
adjuvant.

Calcium balance studies will show increased uptake

of calcium with decreased fecal calcium.

Blood phosphate

and alkaline phosphatase may be normal or elevated.

Other

aids in the diagnosis of sarcoidois include the Kveim reaction,
and tubercle biopsy.

Findings of pulmonary lesions ,.hilar and

(21)

general

lyrr~hadenophaty,

uveoparotid fever, skin lesions,

erythema nodosLLl11, rheumatoid-like arthritis and granulomatous
uveitis should make one suspicious of sarcoidosi.(J3)
The so-called IvIilk Alkali syndrome may present a problem
in the differential diagnosis.

There is usually a history

of excessive milk and absorable alkali ing;estion for the
treatment of peptic ulcer disease.

In addition there is

hypocalcuria and hypophosphaturia" and azotemia as opposed
to the findings in excessive parathormone secretion.

l~[arked

renal insufficiency with alkalosis, azotemia and nephrocalcinosis are also findings. (16) (38)
Immobilization is another cause o.f hypercalcemia. (40)
Especially in the .first

3-4

weeks when bone reabsorption is

at a height and osteoporosis is developing.

However, the

serum phospbate is norT-lal or elevated and tubular phosphate
reabsorption is normal.

Also a trial of therapy (ie) mobil-

ization will cause a drop in serum calcium even to the point
or hypocalcemia.

This cause of hypercalcemia can usually be

elicited by history, but it is an im.portant point to remember
in the treatment of people with Pagets disease and hypercalcemia of other causes.
In multiple myeloma, -ltJoodard {l) has a series of 80
patients in which the average serum Oa++ is 11.1.1-4 mg and 21ft
had a serum. Oa1-+ graa tar than 12.1111g% and another
serllill Oa++ greater than 13.1

mgt.

(22)

157~

had

That this is not due to

.,-.

increased plasma protein is attested to by the fact that it
is the globulins that are increased and the albumin is nor-niBl
or usually decreased.

The albunlin fraction is responsible

for the majority of calcimrl binding.

Also in the vJoodard (1)

series the alkaline phosphatase was greater than

20::b of his patients.

5.1

BU in

The plasma phosphate is usually normal

or elevated in multiple myeloma.

'11his disease can usually

be ruled out by skeletal roentgenograms and appropriate mar'row
aspirations, electrophoresis, and detection of Bence Jones
protein in the urine.
Osteoporosis and osteomalacia are not usually a problem
in the differential diagnosis since sermu Ca++ and POl:: are
L/-

ei ther normal or decreased. (33)
Paget's Disease can present a problem in the differential
diagnosis betli>leen it and pri:mary hyperthyroidism ",Ii th Brown
tml10r formation.

However theseru...rn phosphate is normal or

increased and the phosphate reabsorption test will usually
make the distinction. (36)
Since estrogen therapy has been shown to cause hypercalcemia, it may be contraindicated in certain cases of breast
and prostate carcinoma. (1, 39)

(45)

It has also been postu-

lated that some mechanism is present in the body which can
convert androgens to estrogens and thus produce a hypercalcemia.
Cancer metastatic to bone presents a problem in the
differential diagnosis.

It is generally accepted that in about

9% of all cancers metastatic to bone there is a hypercalcemia

(23)

/

during the course of the disease. (1)

This is apparently

true in all neoplasms except that of the thyroid.

In exten-

sive studies of serum phosphorus the results have ah.rays been
equivocal. (1, 12, 13)

This leads one to believe that these

series may be mixed, that is they may contain both turnors
causing hypercalcemia by excessive osteolysis and exceeding
the renal excretory capacity and also hormone-producing
tuxaors.

There is nothing to prove that these so-called

hormone-producing turnors cannot metastasize to bone and thus
cannot be considered as a factor in the muddled results of
phosphorus metabolism in metastatic bone disease.

Therefore

it seems unlikely that marrow aspiration for tumor cells and
skeletal roentgenograms can decide whether or not one is
dealing with a hormone-producing turnor or not.

Rather the

answer would lie in the phosphorus metabolism or some other
more discrete indicator of excess hormone activity_
The differential diagnosis between primary hyperparathyroidism and parathormone secreting tumors will be covered
in the section titled "discussion".
Other causes of hypercalcemia such as thyrotOXicosis,
Gaucher's disease, Nieman Pick disease, Hand Schuller Christian
Syndrome, Hodgkin's disease, osteogenesis imperfecta, osteomyelitis, xanthomatOSis, chronic radium poisoning, polycythemia vera, etc. must of course be considered.

Idiopathic

hypercalcuria more recently has often been found to be primary hyperthyroidism by more s ensi ti ve tests.

(L!-l)

VI. Discussion
At this point there have been enough well docmnented cases
presented to show the ~xtreme likelihood of the presence of
certain tumors capable of producing a picture very slluilar
if not identical to prLllary hyperparaGhyroidisrn.
Some argue that the hypercalcemia is due to skeletal
metastasis 'lrJ11io11 are so minute that they are undetectable
by radiographic and microscopic m.eans.

This would seem to

be refuted by the observance of these patients over a long
period of time without developm.ent of observable metastasis.
To maintain high enough serum Oa++ levels to supersede to

-

the kidneyst ability to excrete over a. long period of time,
especially in anOl"ectic hypercalcemic cancer patients without
some bony change is inconceivable..

The serum Ca++ also seem

to fall l'>apidly following surgical removal of the twnor.

Some

may argue that this is a phenomenon sirnilar to choriocarcinoma
of the uterus where the metastases seem to disappear following
removal of the primary twnor.

That is, the satell:Lte cancers

are dependent on the primary.

However, small metastases in

soft tissue do not see:m to regress following the removal of
the primary tumor.

Also the presence of the hypophasphatemia

cannot be explained on the basis of unobservable skeletal
metastases.

In aLllost all cases of bone destruction by a

(25)

neoplastic process that is widespread enou{!h to cause hypercalcemia there is normal or slightly increased serUJil phosphorus.
}lyers (12), in one report, shows a serU.lli phosphorus which
rouShly parallels the rise in serum calcium in an exacerbation of metastatic bone disease, although the serwn phosphorus never reaches abnormal levels.

\v11en treatment is

begun the seru:m phosphorus falls along with serum calcivJr1
and a concomitant rise in alkaline phosphatase which signals
the beginning of osteoblastic activity.

Thus in pure metas-

tatic bone disease one sees normal or slightly increased
serum phosphorus levels but not hypophosphatemia.

Although

the serum calcium does rise a phosphate diuresis is not
observed as an attempt to maintain Aca++ • Ap04

=

= K.

One theory that has been advanced is that there is
increased production of an endogenous Vitrunin D like substance
such as in sarcoidosis.

However, calcium balance studies

done by stone and Waterhouse (9) showed that their patient
was in a negative calcium balance of 286 mg per day over a

6 day measurement period when Ca++ intake was
and fecal Ca++ was 307 mg per day.

34l-~

mg per day

This was in spite of

200 mg per day cortisone acetate therapy.
Another explanation that has been advanced is the presence
of an abnormal substance which binds calcium and transports
it in excessive arrwunts, thus accounting for the hypercalcemia by production of a secondary hyperparathYI'oidism.
~

..

(26)

Studies, however, by Plilnpton and Gellhorn, (4) on Howe
fractionation of plasma proteins and eletrophoretic patterns
have shm..rn no abnormal protein.

Also studies to isolate a

circulating mucopolysaccharide have failed, and no calcium
binding lipid or cephalin has been found in adequate amounts
to explain the abnormalities observed.
Schatten, Ship, et 13.1 (14) observed that the spinal
fluid calciml1 was lower than 1rlhat would be expected from the
total serum calcium values and total serum protein.

However

by rapid infusion of human albumin they produced a prompt
rise in total serwn calcium which suggested that the calcium
was normally bound.

Also evidence of ultracentrifuged studies

indicated a normal relationship of bound calcium to serum
protein.

Howard and

cO-~'J'Orkers

(42) have also found that in

primary hyperparathyroidism spinal fluid calcium 1s lower
than one would predict.

In his case of apparent parathormone

activity, Connor (3) found that the spinal calcium was lower
than expected.

Thus this is another parallelism between

primary hyperthyroidism and parathormone secreting tmllors.
It would seem fairly well substantiated that a humoral
substance is produced by some neoplasms.

The problem now

is to decide whether it is: (1) A parathyrotrophic substance,
(2) A substance resembling parathormone but not containing
phosphaturic qualities, (3) :sreakdown products of tml10r with
production of substances with phosphaturic attributes, or

(27)

(4-) Actually parathormone.

Stone and Waterhouse (9) believe that some trophic
substance is produced because they seemingly cured the
hypercalcemia by removal of 3 out of

4

parathyroid glands

thus showing that the hypercalcemia was dependent on the
presence of intact parathyroids.

Secondly, the glands

removed by them were described as resembling secondary
hyperplasia of the parathyroids.

This is, however, the

only case reviewed in which the parathyroids have been described as abnormal.

Their patient progressed rapidly to

death following the operation with hypocalcemia being a
prominent factor in the decline.

A 4th gland was removed

at autopsy and also found to be hyperplastic.
Abouav, et al (15) believes that the hypercalcemia is
due to elaboration of a hurnoral substance by the tumor
which has an action on bone like parathormone but lacks
phosphaturic qualities.

Their patient had nOYillal phosphorus

reabsorption studies (85%), but also a hypophosphatemia and
increased urine

24

hour phosphate excretion.

They account

for the hypophosphatemia on the basis of the body's tendency
to maintain Aca ++.

ApOL~=

= K.

Thus they claim that the

hyperphosphaturia is due to an "attempt by the body to maintain this. constant,n but in fact, one of the major methods of
maintainlng this constant is by phosphaturia which is
mediated through the parathyroid glands.

(28)

If there is a substance produced by some neoplasms
which resembles parathormone in its activity on bone then
it is logical to assume that there would be an increase
in both serum calcium and phosphorus in direct proportion
to their concentration in bone.

This would then exceed

the solubility product of ACa ++ • ApO!..j..::
be metastatic calcification.

=K

and there would

This however does not happen,

but rather there is a decrease in serum phosphate.

Assmning

that the system is receiving an adequate intake of calcium
and phosphorus and that the glomerular filtration rate
remains constant, then the only way for the body's homeostatic mechanisms to lower serum phosphorus would be through
increased tubular activity.

Thus when the body is presented

with an increased load of calcium and phosphorus it responds
by increasing phosphorus excretion.

Therefore per cent

tubular reabsorption studies should show a decrease.
Schaff and Kyle (47) have also shmvn that increasing
serum calcium in normal subjects has no effect on phosphate
per cent tubular reabsorption, but the addition of parathormone lowers the percentage of phosphate reabsorption.
Another possible source for the difference claimed by these
investigators is that their report deals with a masculinizing
ovarian turQor and studies done by them showed increased
serum androgens.

Experimental work has shown nonspecific

effects of adrenal hormones on the parathyroid gland. (43,

(29)

~-4)

Stewart and Bowen (46) have demonstrated a phosphaturic
action of spleen and thyrllUS extracts.

This can thus raise

the possibility that the phosphaturic activity of some of
these tumors is not due to parathormone, but simply tissue
breakdown products.

Sufficient 'lflOrk has not been done in

this field to reach any definite conclusions.
Finally, there is the theory that these twuors secrete
parathormone.

If this is the case then the symptoms and

laboratory findings should be the same as in functioning
parathyroid adenoma because there lrJOuld be continued
release of parathormone unrelated to serum ACa++.

The

laboratory findings in hyperparathyroidism are hypercalcemia,
hypercalicuria, hypophosphatemia, hvperphosphaturia, as well
as some ancillary findings of hyperuricemia, (16) hypokalemic
alkalosiS, increased solute excretion, increased serura citrate
and decreased REG magneshun.

The symptoms of primary hyper-

parathyroidism are due mainly to the hypercalcemia.

The

laboratory diagnosis can be most readily made on the basis
of phosphate reabsorption studies.

Schaaf and Kyle (4.7, L}_8)

showed that in control subjects per cent renal phosphate
reabsorption demonstrated a rr.ean value of 9l.3± 3.3fb.
instances of primary hyperparathYl?oidism averaged

Three

58}:;.

Elevation of serum calcium in normal subjects failed to alter
the normal per cent renal phosphorus reabsorption; hm'll'ever,
Ei.c1di tion of parathyroid lJol'm.one to the calchun infusate produced a fall in per centage to levels similar to those seen

(30)

in primary hyperparathyroidism.

These results were repro-

ducible even in the presence of azotemia.

Goldman and

Bassett (49) indicate that phosphate clearance is well
preserved until G.F.R. is less than

25

mIlmine

Goldsmith

and Ceccarelli (41) have further refined this test and have
been able to justify surgical eXploration in primary stone
formers with hypercalcuria and norrnal serum calcium and
phosphorus.

They have found a high percentage of parathy-

roid adenomas in the so called idiopathic hypercalicurias.
They demonstrated the presence of a morning increase in
phosphorus excretion in normal and hyperparathyroid subjects.
Rapid infusion of calcium causes a reversal of this spontaneous phosphateric rhythm in normal subjects but not in
hyperparathyroid subjects.

Surgical correction of this

disease was follo'\tJed by a normal response to calcium infusion.

These results may help to explain controversial

phosphate reabsorption studies and provide better :means of
control.
The close correlation between primary hyperparathyroidism and parathormone producing turnors is evident.

If

this is the case then a differential diagnosis between the two
should be impossible unless luckily a parathyroid adenom.a
was palpated or picked up on a barima swallow.

An especially

difficult problem would be the presence of' a known malignancy, si,nce the two diseases could both be present.
N'wuerous questions are still in need of answering before

(31)

the presence of a parathormone secreting tu.:mor can actually
be stated with certainty.

One would expect if there were

excessive secretion of pax'athormone the parathyroid glands
themselves would be suppressed and exhibit atrophy.

This

however, has never been the case in the cases reviewed

(3,Q-,5,6,7 ,8,1L.-).

This area could definitely use some

detailed pathologic study by a single investigator.
Another problem is that one would expect these turnors
to show some likeness to each other regarding cellular
patterns and structure.
found.

So far no COIilIllOn structure has been

However, Abouav, et 13.1 (5) stated that their tumor

lvi th apparent para thormone acti vi ty morphologically resembled

parathyroid carcinoma.

Also Schatten, Ship, et 13.1 (14),

found that neither their primary carcinoma of the vulva
nOl'

the first metastasis was associated t'\1ith hyperc8.1cemia.

The picture irJas one of a well diff'erentiated squ8.lnous cell
carcinoma with pearl formation.

The second episode of

metastasis had a hypercalcemia and th:ts tmnor \17aS extremely
anaplastic.

The appal-ent change in function of the tumor

was thus accompanied by an unmistakable change in its histological appearance.
Another interesting observation regarding secretory
activity of neoplasms has been made in regard to excessive
production of ACTH and ADH (51,52,53).

These two substances

are also polypeptides and secretory activity seems to be

(32)

correlated with the degree of anaplasia.

Thus if breakdown

products of turnors can resemble these

products closely

tTtlO

enout;h to function in an endocrine capacity then it is
logical to assume that parathormone can be also produced
by a neoplasm.
To date there have been no reports of osteitis fibrosa
cystica from the influence of the turriors, but rather the main
bone change is just demineralization. (3,4,6,8,14).
",wuld seemingly expect to see this. (28)

One

However, if one

bears in mind that these cells are subjected to many influences other than the changing levels of parathyroid hormone,
it is possible to imagine that under proper conditions
osteoclastic activity will be followed by a compensatory
increase in osteoblastic activity_

Actually in marked

hyperparathyroidism, in spite of compensatory osteoblastic
acti ili ty, the osteoclastic activity predominates, resulting
in the decreased bone density observed radiologically and
the fractures observed clinically.

In other words, the reason

for the development of bone weakness and fractures is not due
to any abnormality of the calcification mechanism but due to
the fact that the predominant cellular activity is osteolysis and such a large percentage of all bone cells are in
this state that, despite all the compensatory physiologic
adjustments, osteoblastic activity is insufficient to maintain
the normal balance bet"'Ieen accretion and resorp"tion.

(33)

In less severe cases it seems likely that the initia.lly
increased osteolysis leads to compensatory increased osteoblastic activity vdth a resulting increased rate of bone
turnover.

This being the case it is misleading to classify

hyperparathyroidism as occuring with or without bone disease.
Changes in bone metabolism undoubtedly occur in all cases of
the disease.

However, the generally used indices of such

changes are so gross that only in moderately severe or longstanding cases of hyperparathyroidism are abnormalities
recorded.

Also in view of the facts (1) that the availability

of phosphate is an important factor in the rate of deposition
of bone matrix, and (2) that the calcium: phosphorus ratio in
the diet will influence the levels of AC ++ and AHp04= in
a
the plasma of hyperparathyroid subjects (and therefore
influences the supply of phosphate available for bone matrix
formation), it is important to point out the role which diet
may play in the rate of progression of the signs of bone disease.
One field in which further developments should elucidate
the hormone producing tumor controversy, is the development
of sensitive assay tests for parathyroid hormone.

To date

attempts at using extracts from tumors have been unsuccessful
in showing any parathyroid activity in eXperimental anilnals

(3).

Tashjian (16), however, has demonstrated the presence

of !!parathyroid hormonel! in extracts of these tumors by use of
an antibody to bovine parathor.mone.

Also Berson, et al (50)

have found that parathyroid hormone concentration in plasma is

(34)

in the range of' .1 to 1.0 millimicrog,-1l1. per milliliter.
This assay technique will surely be sensitive enough to
determine if' these turnors do indeed secrete parathorrnone.

(35)

VII. Surmnary and Conclusions
A series of patients from the literature with malignant
neoplasms without bone metastasis has been presented in
which a syndrome resembling primary hyperparathyroidism has
been found.

It is postulated that these tumors secrete

parathyroid hormone and that the excess hormone is responsible for the hypercalcemia, hypercalicuria, hypophosphatemia
and hyperphosphasturia found in these patients.

The signs

of excess hormone production are reduced by surgical removal
or chemotherapeutic treatment of the neoplasms.
tend to recur with recurrence of the neoplasm.

They also
There is no

typical histological pattern on these neoplasms and they
arise from numerous primary sites.

However, there is some

correlation between changes in the histologic pattern of
the turnor and amount of hormone production.
One investigator has found parathyroid hormone in the
neoplasm and this is the area where further research will
probably either refute or solidify the subject of this thesis.
The work being done in this area is valuable for many
reasons.

It may be used as a screening agent for occult

neoplasms.

It can be used as a guide to therapy and also

in the screening of the effectiveness of various anti-cancer
drugs.

Also it can help to develop

efl~ective

treatment for

the hypercalcemia which complicates the therapy of many terminal cancers.

(36)

No definite conclusions can be reached, but it is this
writerts opinion that such neoplasms do exist and that this
will eventually be confirmed by pathologic histology and
hormone assay studies.

(37)
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